Provided by Tiger Fintech (Singapore) Pte. Ltd.

Achieve Life Sciences, Inc.

2.40
-0.0300-1.23%
Volume:167.27K
Turnover:401.66K
Market Cap:83.24M
PE:-1.93
High:2.49
Open:2.45
Low:2.37
Close:2.43
Loading ...

Equity Markets Close Lower as Trump Calls on Fed for Rate Cuts

MT Newswires Live
·
22 Apr

BRIEF-Achieve Life Sciences Says Cytisinicline NDA Submission To FDA Planned For June 2025

Reuters
·
22 Apr

Achieve Life Sciences Expects to File New Drug Application in US for Smoking Cessation Medication

MT Newswires Live
·
22 Apr

Achieve Life Sciences announces publication of results from Phase 3 ORCA-3 trial

TIPRANKS
·
21 Apr

Achieve Life Sciences Announces Cytisinicline Phase 3 Orca-3 Trial Publication on Smoking Cessation in Jama Internal Medicine

THOMSON REUTERS
·
21 Apr

Achieve Life Sciences Inc - Cytisinicline Nda Submission to FDA Planned for June 2025

THOMSON REUTERS
·
21 Apr

Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory

Insider Monkey
·
21 Mar

Q4 2024 Achieve Life Sciences Inc Earnings Call

Thomson Reuters StreetEvents
·
12 Mar

Achieve Life Sciences Inc (ACHV) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...

GuruFocus.com
·
12 Mar

Analysts Are Bullish on Top Healthcare Stocks: Achieve Life Sciences (ACHV), Dexcom (DXCM)

TIPRANKS
·
12 Mar

Lake Street Keeps Their Buy Rating on Achieve Life Sciences (ACHV)

TIPRANKS
·
11 Mar

Achieve Life Sciences Q4 EPS $(0.36) Misses $(0.32) Estimate

Benzinga
·
11 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
11 Mar

Achieve Life Sciences Inc expected to post a loss of 32 cents a share - Earnings Preview

Reuters
·
07 Mar

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025

GlobeNewswire
·
06 Mar

Here are Rogue Funds Updates on Achieve Life Sciences (ACHV)

Insider Monkey
·
18 Feb

Achieve Life Sciences (ACHV) Gets a Buy from Lake Street

TIPRANKS
·
10 Feb

Achieve Life Sciences Inc - Reiterates Planned Nda Submission for Cytisinicline in Q2 2025

THOMSON REUTERS
·
10 Feb

Achieve Life Sciences Inc - Dsmc Finds No Unexpected Adverse Events in Orca-Ol Trial

THOMSON REUTERS
·
10 Feb

Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the Orca-Ol Clinical Trial

THOMSON REUTERS
·
10 Feb